Depression denials in California external review
In the California DMHC record, independent physician reviewers decided 1,098 published external-review cases involving depressionand overturned the plan’s denial in 56.6%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.
Most-fought treatments for depression
| Treatment | Decisions | Overturned |
|---|---|---|
| Residential Treatment Center | 400 | 69% |
| Intensive Outpatient Program | 106 | 73.6% |
| Partial Hospitalization Program | 99 | 66.7% |
| Residential Treatment | 67 | 43.3% |
| TMS | 31 | 35.5% |
| Individual Psychotherapy | 25 | 64% |
| Psychotherapy | 22 | 59.1% |
| Provigil | 22 | 40.9% |
| Residential Treatment Center Admission | 21 | 38.1% |
| Inpatient Psychiatric Hospitalization | 19 | 47.4% |
| Lexapro | 12 | 41.7% |
What the insurer actually argued
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 1,036 | 59.3% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 50 | 12% |
Urgent Care Expedited reviews, decided in days rather than weeks. | 12 | 16.7% |
What the reviewers wrote
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for Residential Treatment Center (RTC) services.At issue in this case is whether the RTC services that were provided to treat the patient’s mental health or substance use disorder were medically necessary as defined in Health and Safety Code section 1374.72(a)(3)(A). The American Academy of Child and Adolescent Psychiatry (AACAP) & American Association for Community Psychiatry (AACP) have unified the Child & Adolescent Level of Care Utilization System (CALOCUS) & the Child and Adolescent Service Intensity Instrument (CASII) into a single instrument, the CALOCUS-CASII. This instrument is a standardized tool used to determine the intensity of services needed for children & adolescents, 6-18 years of age, presenting with psychiatric, substance use, medical &/or developmental concerns.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement and prospective authorization and coverage for residential treatment center (RTC) services (ASAM 3.1). Per the American Society of Addiction Medicine (ASAM) criteria, this patient meets Level 3.1 criteria for RTC services. ASAM criteria focus on six dimensions to determine the appropriate level of care, which includes: 1)intoxication and withdrawal potential; 2)biomedical conditions; 3)emotional, behavioral, and cognitive conditions; 4)readiness to change; 5)relapse, continued use, or continued problem potential; and 6)recovery environment. For dimension 1, the patient did not have any symptoms of acute withdrawal during the time period under review. Given these findings, the patient meets ASAM 3.1 requirements for this dimension.
Where the denial was upheld
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for residential treatment center (RTC) services (ASAM 3.5). Per the American Society of Addiction Medicine (ASAM) criteria, this patient does not meet the Level 3.5 criteria for RTC services. ASAM criteria focus on six dimensions to determine the appropriate level of care, which includes: (1) intoxication and withdrawal potential; (2) biomedical conditions; (3) emotional, behavioral, and cognitive conditions; (4) readiness to change; (5) relapse, continued use, or continued problem potential; and (6) recovery environment. For dimension 1, the patient had no signs or symptoms of withdrawal after detoxification was completed. Given these findings, the patient met ASAM 3.5 requirements for this dimension.For dimension 2, the patient had no medical problems.
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement and prospective authorization and coverage for residential treatment center (RTC) services (ASAM 3.5). Per the American Society of Addiction Medicine (ASAM) criteria, this patient does not meet Level 3.5 criteria for RTC services from 7/28/22 forward. The ASAM criteria focuses on six dimensions to determine the appropriate level of care, which includes: (1) intoxication and withdrawal potential; (2) biomedical conditions; (3) emotional, behavioral and cognitive conditions; (4) readiness to change; (5) relapse, continued use, or continued problem potential; and (6) recovery environment. For dimension 1, the patient no longer had withdrawal symptoms per the records. The patient’s withdrawal needs can be safely managed in a Level 3.5 setting.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
A diagnosis does not by itself establish treatment intensity. See the separate record for residential, PHP, IOP, inpatient, and withdrawal-management denials: behavioral-health level-of-care evidence guide.
These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving depression, then check the rights and deadlines that apply to your plan.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY